FR1143M - Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia. - Google Patents

Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.

Info

Publication number
FR1143M
FR1143M FR862157A FR862157A FR1143M FR 1143 M FR1143 M FR 1143M FR 862157 A FR862157 A FR 862157A FR 862157 A FR862157 A FR 862157A FR 1143 M FR1143 M FR 1143M
Authority
FR
France
Prior art keywords
pyimidic
uricemia
hypercholesterolemia
hyper
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR862157A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PERRIER LAB
Original Assignee
PERRIER LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PERRIER LAB filed Critical PERRIER LAB
Priority to FR862157A priority Critical patent/FR1143M/en
Application granted granted Critical
Publication of FR1143M publication Critical patent/FR1143M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR862157A 1961-05-17 1961-05-17 Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia. Expired FR1143M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR862157A FR1143M (en) 1961-05-17 1961-05-17 Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR862157A FR1143M (en) 1961-05-17 1961-05-17 Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.

Publications (1)

Publication Number Publication Date
FR1143M true FR1143M (en) 1962-02-26

Family

ID=87884453

Family Applications (1)

Application Number Title Priority Date Filing Date
FR862157A Expired FR1143M (en) 1961-05-17 1961-05-17 Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.

Country Status (1)

Country Link
FR (1) FR1143M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761221A1 (en) * 1995-08-17 1997-03-12 WÖRWAG PHARMA GmbH Use of orotic acid for the preparation of a medicament for prophylaxis and therapy of metabolic syndrom

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761221A1 (en) * 1995-08-17 1997-03-12 WÖRWAG PHARMA GmbH Use of orotic acid for the preparation of a medicament for prophylaxis and therapy of metabolic syndrom

Similar Documents

Publication Publication Date Title
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3139M (en) Secondary and tertiary 1-halophenyl-2-amino-alkanones- (1) has therapeutic properties.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1180M (en) Medicinal product based on a derivative of uracyl, intended in particular for the treatment of hyperuricemia and hypercholesterolemia.
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2433M (en) Medicinal product based on 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-quinoline and 6- (5'-diethylaminopentyl-2'-amino) -5,8-dimethoxy-2-methyl -quinoline for the prophylactic and curative treatment of malaria.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1404M (en) Medicinal product for the treatment of atherosclerosis, hypercholesterolemia and certain liver diseases, based on a new magnesium phosphatides-hyposulfite complex.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR2093M (en) Medicinal product based on a hydroxy-dibenzocycloheptane derivative.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.